Published by Josh White on 3rd April 2025
(Sharecast News) - Faron Pharmaceuticals announced on Thursday that it has entered into a financing arrangement with an entity managed by Heights Capital Management for up to €35m in convertible bonds, issuing an initial €15m tranche to repay existing debt and bolster its financial position ahead of a key clinical readout.